(Q331626)

Statements

0 references

addresses subject

770

1 reference

https://openalex.org/I4210150756

Advancements in Lung Cancer Research

620

1 reference

https://openalex.org/I4210150756

Management of Diabetes Mellitus and Cardiovascular Risk

587

1 reference

https://openalex.org/I4210150756

Cancer Immunotherapy

446

1 reference

https://openalex.org/I4210150756

Genomic Landscape of Cancer and Mutational Signatures

395

1 reference

https://openalex.org/I4210150756

Standardisation and Management of COPD

359

1 reference

https://openalex.org/I4210150756

Health Economics and Quality of Life Assessment

355

1 reference

https://openalex.org/I4210150756

Therapeutic Antibodies: Development, Engineering, and Applications

315

1 reference

https://openalex.org/I4210150756

Pulmonary Drug Delivery Techniques

310

1 reference

https://openalex.org/I4210150756

Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy

302

1 reference

https://openalex.org/I4210150756

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

287

1 reference

https://openalex.org/I4210150756

Diagnosis and Management of Chronic Cough

282

1 reference

https://openalex.org/I4210150756

Global Challenge of Antibiotic Resistance in Bacteria

263

1 reference

https://openalex.org/I4210150756

Computational Methods in Drug Discovery

252

1 reference

https://openalex.org/I4210150756

Management of Diabetes Mellitus and Hypoglycemia

235

1 reference

https://openalex.org/I4210150756

Advancements in Colorectal Cancer Research

229

1 reference

https://openalex.org/I4210150756

Cholesterol-lowering Treatment

221

1 reference

https://openalex.org/I4210150756

Diagnosis and Management of Gastroesophageal Reflux Disease

209

1 reference

https://openalex.org/I4210150756

Pharmacokinetics of Antibiotics in Critically Ill Patients

200

1 reference

https://openalex.org/I4210150756

Lymphoid Neoplasms

200

1 reference

https://openalex.org/I4210150756

Small Cell Lung Cancer

198

1 reference

https://openalex.org/I4210150756

Role of AMP-Activated Protein Kinase in Cellular Metabolism

198

1 reference

https://openalex.org/I4210150756

Statistical Methods in Clinical Trials and Drug Development

197

1 reference

https://openalex.org/I4210150756

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

190

1 reference

https://openalex.org/I4210150756

Management of Hyperkalemia in Kidney Diseases

189

1 reference

https://openalex.org/I4210150756

coordinate location

39°47'9"N, 75°32'56"W

1 reference

https://openalex.org/I4210150756

United States of America

1 reference

https://openalex.org/I4210150756

official website

http://www.astrazeneca-us.com/home/

1 reference

https://openalex.org/I4210150756

0 references

Research Organization Registry ID

0 references

is subsidiary of

AstraZeneca (United Kingdom)

1 reference

https://openalex.org/I4210150756

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331626&oldid=1268046"